Characterization of Primary Cultures of Normal and Neoplastic Canine Melanocytes.
cutaneous melanoma
dog
melanocytes
mucosal melanoma
primary cell culture
Journal
Animals : an open access journal from MDPI
ISSN: 2076-2615
Titre abrégé: Animals (Basel)
Pays: Switzerland
ID NLM: 101635614
Informations de publication
Date de publication:
10 Mar 2021
10 Mar 2021
Historique:
received:
23
02
2021
revised:
03
03
2021
accepted:
04
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
4
4
2021
Statut:
epublish
Résumé
Although numerous animal models, especially mouse models, have been established for the study of melanoma, they often fail to accurately describe the mechanisms of human disease because of their anatomic, physiological, and immune differences. The dog, as a spontaneous model of melanoma, is nowadays considered one of the most valid alternatives due to the heterogeneity of clinical presentations and of histological and genetic similarities of canine melanoma with the human counterpart. The aim of the study was to optimize a protocol for the isolation and cultivation of healthy and neoplastic canine melanocytes derived from the same animal and obtained from cutaneous and mucosal (oral) sites. We obtained five primary tumor cell cultures (from 2 cutaneous melanoma, 2 mucosal melanoma and 1 lymph node metastasis) and primary normal melanocyte cell cultures (from normal skin and mucosa) from the same dogs. Immunocytochemical characterization with Melan A, PNL2 and S100 antibodies confirmed the melanocytic origin of the cells. This work contributes to expanding the case record of studies on canine melanoma cell cultures as suitable model to study human and canine melanoma. To the authors' knowledge, this is the first report of isolation of normal skin and mucosal canine melanocytes.
Identifiants
pubmed: 33802040
pii: ani11030768
doi: 10.3390/ani11030768
pmc: PMC7998744
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Fondazione Cassa di Risparmio di Perugia
ID : 2017.0238.021
Références
Cytotechnology. 2014 Dec;66(6):891-8
pubmed: 24113919
Int J Clin Exp Med. 2010 Feb 22;3(1):69-83
pubmed: 20369042
Spermatogenesis. 2012 Jan 1;2(1):1-5
pubmed: 22553484
Vet Comp Oncol. 2020 Sep;18(3):269-280
pubmed: 31665821
PLoS One. 2017 Mar 6;12(3):e0173400
pubmed: 28264026
Genes (Basel). 2019 Jun 30;10(7):
pubmed: 31262050
J Vet Med Sci. 2004 Nov;66(11):1437-40
pubmed: 15585963
J Vet Med A Physiol Pathol Clin Med. 2002 May;49(4):198-202
pubmed: 12069262
Vet Sci. 2016 Feb 19;3(1):
pubmed: 29056717
Rev Invest Clin. 2019;71(6):369-380
pubmed: 31823965
Exp Ther Med. 2013 Oct;6(4):967-972
pubmed: 24137299
Exp Dermatol. 2018 May;27(5):578-586
pubmed: 29697862
Cancer Immunol Immunother. 2019 Nov;68(11):1839-1853
pubmed: 31222484
Vet Pathol. 2019 Mar;56(2):189-199
pubmed: 30381008
Stem Cells Dev. 2020 Jul;29(14):919-928
pubmed: 32423311
BMC Cancer. 2018 Dec 4;18(1):1219
pubmed: 30514258
Vet Pathol. 2011 Jan;48(1):54-72
pubmed: 21266721
Int J Mol Sci. 2018 Jan 30;19(2):
pubmed: 29385676
Pigment Cell Melanoma Res. 2014 Jan;27(1):90-102
pubmed: 24112648
J Pathol. 2020 Sep;252(1):4-21
pubmed: 32652526
Vet Ophthalmol. 2015 Jul;18(4):285-90
pubmed: 25176505
Methods Mol Biol. 2019;1879:243-256
pubmed: 29582376
J Vis Exp. 2013 Mar 13;(73):e50200
pubmed: 23525090
Pigment Cell Res. 2003 Aug;16(4):407-10
pubmed: 12859625
Pigment Cell Melanoma Res. 2014 Jan;27(1):37-47
pubmed: 24128326
Exp Dermatol. 2014 Jan;23(1):18-9
pubmed: 24372649
Am J Dermatopathol. 2013 Apr;35(2):248-51
pubmed: 23249835
J Vet Sci. 2017 Mar 30;18(1):101-104
pubmed: 27456773
Vet Clin Pathol. 2015 Dec;44(4):597-604
pubmed: 26398102